Codexis Acquires Biocatalytics

ID
114594

DATE

2007-07-19

target

Biocatalytics, Inc.

Pasadena, California
United States
Biocatalytics, Inc. is a private company that has produced custom and off-the-shelf enzymes used in chemical process manufacturing by pharmaceutical and fine chemical companies.
(Show More)

Search 121,128 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Get Started

Acquirer 1

Acquirer DESCRIPTION

Codexis, Inc.

COMPANY
Redwood City, California
United States
www.codexis.com

Life Science

91

50M USD (2017)

Codexis, Inc.

Codexis, Inc. is a developer of biocatalysts or enzymes that initiate and accelerate a chemical reaction. Codexis' technologies bring improved manufacturing approaches to sectors ranging from the pharmaceutical industry, fine chemicals, flavors and fragrances, to animal health, food and nutrition, agrochemicals and carbon capture. Codexis, Inc. was formed in 2002 and is headquartered in Redwood City, California.


DEAL STATS #
Acquisition 2 of 2
Sector (Chemicals) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (California) 1 of 1
Country (United States) 1 of 1
Year (2007) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-22 Julich Fine Chemicals GmbH Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-17 Codexis Laboratories Hungary Kft. Sell -